Hematuria Treatment Medication in New Hampshire Could Increase Death Rate

NEW HAVEN, Conn.

— New Hampshire Gov.

Maggie Hassan said Friday that a medication that could be used to treat hematurias could cause an increase in deaths.

Hassan said she had not heard of any deaths related to the treatment medication hematura, but that it has been reported that a man in Colorado died from hematuriasis complications.

The governor said that in a statement, the state health department has looked into reports of death, but had not found evidence to indicate that the medication could cause a spike in deaths from a disease that is treatable with conventional medical treatments.

A spokeswoman for the state Department of Health said the department is working with state and federal health officials to assess the use of hematuras.

In January, New Hampshire began the use, for people with hematuric conditions, of a new drug called thrombin, also known as platelet boosting medication.

It is used to prevent blood clots and clotting problems caused by blood clumps and thrombotic disorders.

Thrombin is given intravenously, by a doctor or nurse.

Doctors and nurses must be able to read the drug label.

The label includes the dosage, the expected length of treatment, and the frequency of injections, if necessary.